About LordsMed
Lord’s Mark is ISO 13485 & ISO 9001 company.
LordsMed is ISO 13485 & ISO 9001 company with a vision to launch innovative products in Diagnostics Category. We offer complete range of analysers, reagents for clinical biochemistry, haematology, immunology, rapids (ICMR approved Antigen kit) & Lab consumables. Company has filed patent for Biochemistry reagents & 1st in India AI based Sickle cell Rapid Kit – ShapeDX
Our Certification









Directors Message

Over the past few years, the world has undergone a profound transformation. The pandemic not only reshaped lives but also redefined how businesses operate and evolve. At Lords, we saw this change as a call to action—a moment to diversify, innovate, and rise to meet new challenges.
With a proud legacy spanning 26 years, we have consistently placed technology and innovation at the forefront of everything we do. Today, as we chart the path forward, sustainability and impact-driven solutions are the guiding principles behind our latest ventures. Whether it’s in MedTech, Diagnostics, Renal Care, or Surgical products, our mission is to empower healthcare with accessible, reliable, and future-ready solutions.
Our journey has also expanded into new territories with our sister companies—Lords Automative, Lords Mark Insurance Broking, and Brahamastra—each reinforcing our commitment to excellence and purposeful growth.
At Lords, we remain deeply committed to creating value for all our stakeholders. We invite you to be a part of this exciting journey, as we continue to innovate, inspire, and lead with purpose.
Warm regards,
Sachidanand Upadhyay
Managing Director & CEO, Lord’s Mark Group
Our Certification









Our Journey
From a vision to transform healthcare access in India to partnering with premier institutes like IIT Bombay and BARC, the LordsMed journey is one of innovation, purpose, and progress.
-
March 2020
Launch of LordsMed division
-
April 2020
Partnership with Indian Pharma MNC for distribution of Sanitizer products in B2G segment
-
September 2020
Entered distribution of Generic Drugs in B2G segment
-
November 2020
Entered Diagnostics business
-
June 2021
Entered unique distribution partnership with MedTech product company for Remote Patient Monitoring system
-
June 2021
ICMR approved LordsMed Antigen Kit
-
June 2021
ICMR approval for LordsMed Antigen Kit Launched Sanitary Pads- Safelite
-
November 2021
Entered 5 years Partnership with Braithwaite- PSU: Ministry of Railways
-
October 2022
Launched IVD Manufacturing Unit at Vasai, Maharashtra, India
-
November 2021
Entered 5 years Partnership with Braithwaite- PSU: Ministry of Railways
-
October 2022
Launched IVD Manufacturing Unit at Vasai, Maharashtra, India
-
May 2023
Technology transfer partnership with IIT Bombay for AI Based Sickle Cell Rapid Kit
-
September 2023
Technology transfer partnership with BARC for Oral Cancer Device
-
January 2024
Inaugurated 1st LordsMed Pathology Lab Center in Maharashtra
Company Files patent for Biochemistry Reagent
-
February 2024
Launch of Esmart Clinic with MOU signed with Unnat Bharat Abhiyan at IIT Delhi with first project inaugurated at AIIMS Rajkot
-
October 2024
Launched Surgical Manufacturing at Silvassa
-
April 2025
Secures a $1 million MedTech order for the US market
Our Journey
-
March 2020
Launch of LordsMed division
-
April 2020
Partnership with Indian Pharma MNC for distribution of Sanitizer products in B2G segment
-
September 2020
Entered distribution of Generic Drugs in B2G segment
-
November 2020
Entered Diagnostics business
-
June 2021
Entered unique distribution partnership with MedTech product company for Remote Patient Monitoring system
-
June 2021
ICMR approved LordsMed Antigen Kit
-
June 2021
ICMR approval for LordsMed Antigen Kit Launched Sanitary Pads- Safelite
-
November 2021
Entered 5 years Partnership with Braithwaite- PSU: Ministry of Railways
-
October 2022
Launched IVD Manufacturing Unit at Vasai, Maharashtra, India
-
November 2021
Entered 5 years Partnership with Braithwaite- PSU: Ministry of Railways
-
October 2022
Launched IVD Manufacturing Unit at Vasai, Maharashtra, India
-
May 2023
Technology transfer partnership with IIT Bombay for AI Based Sickle Cell Rapid Kit
-
September 2023
Technology transfer partnership with BARC for Oral Cancer Device
-
January 2024
Inaugurated 1st LordsMed Pathology Lab Center in Maharashtra
Company Files patent for Biochemistry Reagent
-
February 2024
Launch of Esmart Clinic with MOU signed with Unnat Bharat Abhiyan at IIT Delhi with first project inaugurated at AIIMS Rajkot
-
October 2024
Launched Surgical Manufacturing at Silvassa
-
April 2025
Secures a $1 million MedTech order for the US market
Leadership Team
Our Leadership believes in Action and not Position!
We are a team of more than 46,000+ people across the globe working for a common purpose. We are led by one of India’s most visionary Chairman who is supported by a talented and experienced management team.

Mr. Sachidanand Upadhyay
MD & CEO

MR. Manav teli
Director

Mr. Vijay Borkar
Director (operation)

Mr.Vinay Sarda
Director
March 2020
Launch of LordsMed division
April 2020
Partnership with Cipla for distribution of Ciphand products in B2G segment
September 2020
Entered distribution of Generic Drugs in B2G segment
November 2020
Entered Diagnostics business
April 2021
Entered manufacturing of Generic Drugs
June 2021
Entered 5 years distribution partnership with MedTech Startup- Dozee (Remote Patient monitoring device for Step down HDU)
June 2021
ICMR approval for LordsMed Antigen Kit Launched Sanitary Pads- Safelite
July 2021
Launched The Hygiene India Ecommerce initiative – Umbrella brand – SafeSehat & MarkoSafe
September 2021
Launched Lord’s Sehat- Walk-in clinics, equipped with integrated point of care diagnostics
November 2021
Entered 5 years Partnership with Braithwaite- PSU: Ministry of Railways
December 2021
Launch of LordsMed Air Ionizer
January 2022
Distribution Partnership with Mylab for Coviself Home test kit
Visit the Main website for details
Our Subsidiaries
#HameshaAapkeSaath



